Whilst whole-body removal of CXADR promotes pathological cardiac responses, the protective effects of endothelium-specific CXADR knockout against myocardial inflammation, established cardiac dysfunction, shock, and subsequent death suggest the potential of selectively inhibiting endothelial CXADR expression as a therapeutic strategy for inflammatory heart disease. The gene discussed is CXADR; the disease is myocarditis.